Expression of Toll-like receptors in oral squamous cell carcinoma

PLoS One. 2024 Apr 9;19(4):e0300437. DOI: 10.1371/journal.pone.0300437 eCollection 2024.

Peter Rusanen, Emilia Marttila, Sajeen Bahadur Amatya, Jaana Hagström, Johanna Uittamo, Justus Reunanen, Riina Rautemaa-Richardson, Tuula Salo

https://pubmed.ncbi.nlm.nih.gov/38593176

National Institute for Health and Care Excellence (NICE) guidance on monitoring and management of Barrett’s oesophagus and stage I oesophageal adenocarcinoma

Gut. 2024 Mar 29:gutjnl-2023-331557. DOI: 10.1136/gutjnl-2023-331557 Online ahead of print.

Massimiliano di Pietro, Nigel J Trudgill, Melina Vasileiou, Gaius Longcroft-Wheaton, Alexander W Phillips, James Gossage, Philip V Kaye, Kieran G Foley, Tom Crosby, Sophie Nelson, Helen Griffiths, Muksitur Rahman, Gill Ritchie, Amy Crisp, Stephen Deed, John N Primrose

https://pubmed.ncbi.nlm.nih.gov/38553042

International consensus is needed on a core outcome set to advance the evidence of best practice in cancer prehabilitation services and research

Br J Anaesth. 2024 Mar 23:S0007-0912(24)00100-4. DOI: 10.1016/j.bja.2024.02.021 Online ahead of print.

Anna M Myers, Rachael C Barlow, Gabriele Baldini, Anna M Campbell, Franco Carli, Esther J Carr, Tom Collyer, Gerard Danjoux, June F Davis, Linda Denehy, James Durrand, Chelsia Gillis, Diana M Greenfield, Stuart P Griffiths, Mike Grocott, Liam Humphreys, Sandy Jack, Carol Keen, Denny Z H Levett, Zoe Merchant, John Moore, Susan Moug, William Ricketts, Daniel Santa Mina, John M Saxton, Clare E Shaw, Garry A Tew, Michael Thelwell, Malcolm A West, Robert J Copeland

https://pubmed.ncbi.nlm.nih.gov/38522964

Frontline and Relapsed Rhabdomyosarcoma (FAR-RMS) Clinical Trial: A Report from the European Paediatric Soft Tissue Sarcoma Study Group (EpSSG)

Cancers (Basel). 2024 Feb 29;16(5):998. DOI: 10.3390/cancers16050998

Julia Chisholm, Henry Mandeville, Madeleine Adams, Veronique Minard-Collin, Timothy Rogers, Anna Kelsey, Janet Shipley, Rick R van Rijn, Isabelle de Vries, Roelof van Ewijk, Bart de Keizer, Susanne A Gatz, Michela Casanova, Lisa Lyngsie Hjalgrim, Charlotte Firth, Keith Wheatley, Pamela Kearns, Wenyu Liu, Amanda Kirkham, Helen Rees, Gianni Bisogno, Ajla Wasti, Sara Wakeling, Delphine Heenen, Deborah A Tweddle, Johannes H M Merks, Meriel Jenney

https://pubmed.ncbi.nlm.nih.gov/38473359

Translational use of homing peptides: Tumor and placental targeting

J Colloid Interface Sci. 2024 Feb 13:662:1033-1043. DOI: 10.1016/j.jcis.2024.02.103 Online ahead of print.

Abdulaziz A Alobaid, Maximilian W A Skoda, Lynda K Harris, Richard A Campbell

https://pubmed.ncbi.nlm.nih.gov/38387365/

Real-World Concordance between Germline and Tumour BRCA1/2 Status in Epithelial Ovarian Cancer

Cancers (Basel). 2023 Dec 29;16(1):177. DOI: 10.3390/cancers16010177

Robert D Morgan, George J Burghel, Helene Schlecht, Andrew R Clamp, Jurjees Hasan, Claire L Mitchell, Zena Salih, Joseph Shaw, Sudha Desai, Gordon C Jayson, Emma R Woodward, D Gareth R Evans

https://pubmed.ncbi.nlm.nih.gov/38201604/

Randomised phase III trial of the hypoxia modifier nimorazole added to radiotherapy with benefit assessed in hypoxic head and neck cancers determined using a gene signature (NIMRAD)

Int J Radiat Oncol Biol Phys. 2023 Dec 8:S0360-3016(23)08184-1. DOI: 10.1016/j.ijrobp.2023.11.055 Online ahead of print.

Professor David Thomson, Professor Nick Slevin, Helen Baines, Guy Betts, Steve Bolton, Professor Mererid Evans, Kate Garcez, Joely Irlam, Lip Lee, Nicola Melillo, Hitesh Mistry, Elisabet More, Professor Christopher Nutting, James Price, Stefano Schipani, Mehmet Sen, Huiqi Yang, Professor Catharine West NIMRAD Trial Group

https://pubmed.ncbi.nlm.nih.gov/38072326/

Predicting risk of endometrial cancer in asymptomatic women (PRECISION): Model development and external validation

BJOG. 2023 Dec 10. DOI: 10.1111/1471-0528.17729 Online ahead of print.

Sarah J Kitson, Emma J Crosbie, D Gareth Evans, Aritaya Lophatananon, Kenneth R Muir, Darren Ashcroft, Evan Kontopantelis, Glen P Martin

https://pubmed.ncbi.nlm.nih.gov/38073256/

Ibrutinib as first line therapy for mantle cell lymphoma: A multicentre, real-world UK study

Blood Adv. 2023 Dec 21:bloodadvances.2023011152. DOI: 10.1182/bloodadvances.2023011152 Online ahead of print.

Ann Tivey, Rohan Shotton, Toby A Eyre, David Lewis, Louise Stanton, Rebecca Allchin, Harriet Sarah Walter, Fiona Miall, Rui Zhao, Anna Santarsieri, Rory McCulloch, Mark Bishton, Amy Beech, Victoria Clare Willimott, Nicole Fowler, Claudia Bedford, Jack Goddard, Samuel Protheroe, Angharad Everden, David L Tucker, Joshua Wright, Srivasavi Dukka, Miriam Thomson, Shankara Paneesha, Mahesh Prahladan, Andrew Hodson, Iman Qureshi, Manasvi Koppana, Mary Owen, Kushani Ediriwickrema, Helen Marr, Jamie Wilson, Jonathan Lambert, David J Wrench, Claire N Burney, Chloe Knott, Georgina Talbot, Adam Gibb, Angela Lord, Barry Jackson, Simon Stern, Taylor Sutton, Amy Caitlin Webb, Marketa Wilson, Nicky Thomas, Jane Norman, Elizabeth Davies, Lisa Lowry, Jamie Maddox, Neil Phillips, Nicola Crosbie, Marcin Flont, Emma Lm Nga, Andres Virchis, Raisa Guerrero Camacho, Wunna Swe, Arvind Radhakrishna Pillai, Clare Rees, James Bailey Dr, Steve Gareth Jones, Susan Smith, Faye Sharpley, Catherine Hildyard, Sajir Mohamedbhai, Toby Nicholson, Simon Moule, Anshuman Chaturvedi, Kim Linton

https://pubmed.ncbi.nlm.nih.gov/38127279/

Multimodality local consolidative treatment versus conventional care of advanced lung cancer after first-line systemic anti-cancer treatment: study protocol for the RAMON multicentre randomised controlled trial with an internal pilot

BMJ Open. 2023 Dec 10;13(12):e081650. DOI: 10.1136/bmjopen-2023-081650

Chloe Beard, Chris A Rogers, Leah Fleming, John Conibear, Matthew Evison, Thomas Newsom-Davis, Tara Barwick, Nicola Mills, Elizabeth A Stokes, Paulo De Sousa, Tim Batchelor, Janette Rawlinson, Sarah Baos, Rosie Harris, Eric Lim

https://pubmed.ncbi.nlm.nih.gov/38072470/